Related Experiment Video
Updated: May 22, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
CNS dopamine transmission mediated by noradrenergic innervation
Caroline C Smith1, Robert W Greene
1Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Summary
The locus ceruleus, not the VTA, may be the source of dopamine in the hippocampus. This dopamine release enhances synaptic transmission, suggesting a role for noradrenergic fibers in central nervous system dopamine regulation.
Area of Science:
- Neuroscience
- Neuropharmacology
- Synaptic Transmission
Background:
- The source of presynaptic dopamine in the hippocampus CA1 region remains unclear due to anatomical discrepancies between dopaminergic terminals and receptors.
- Dopamine D1 receptor (D1R)-mediated enhancement of glutamate synaptic transmission is observed following amphetamine exposure, suggesting endogenous dopamine release.
Purpose of the Study:
- To investigate the source of endogenous dopamine release in the hippocampus CA1 region.
- To elucidate the role of the ventral tegmental area (VTA) and locus ceruleus (LC) in dopamine-mediated synaptic enhancement.
Main Methods:
- In vitro hippocampal slice preparation from C57BL/6 male mice.
- Amphetamine administration to induce endogenous dopamine release.
- Manipulation of tyrosine hydroxylase (TH) expression in VTA and LC via siRNA and viral vectors.
- Pharmacological blockade of dopamine transporter (DAT) and norepinephrine (NE) transporter.
Main Results:
- Amphetamine-induced D1R-mediated synaptic enhancement was not affected by VTA TH knockdown or DAT blockade.
- Decreasing TH expression in the LC or blocking the NE transporter prevented the dopamine-mediated response.
- These results indicate that noradrenergic fibers from the LC may release dopamine in the hippocampus.
Conclusions:
- Noradrenergic fibers originating from the locus ceruleus may be the primary source of dopamine release in the hippocampus.
- The locus ceruleus may play a significant role in central nervous system dopamine transmission, particularly in response to drugs of abuse and under physiological conditions.
Related Concept Videos
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:30Classification of Neurotransmitters
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...